Dr. Rupal Jayprakash Shah, MD

Dr. Shah practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Shah's NPI, 1396937264, was assigned on August 15, 2007. Dr. Shah graduated from Wayne State University School Of Medicine in 2005. Dr. Shah's Pennsylvania license number on file is MD436473.

Dr. Shah's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Shah's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Shah to 3 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shah practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Shah's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Shah is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Shah's licenses on file in 4 states: Pennsylvania, Maine, California and New York.

Dmand AI lists chronic lung disease and pulmonary fibrosis among the conditions Dr. Shah treats.

CMS data shows 596 Medicare services from Dr. Shah across 10 procedure codes in 2024, for 183 Medicare patients. Medicare paid $50,462 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 183 Medicare patients who saw Dr. Shah in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shah's median patient age at 68, with 50% women.

In 2024, Dr. Shah wrote 1,588 Medicare Part D claims for 240 patients. 86% of them were for generic drugs. CMS names the drug for 1,348 of them, across 27 drugs with 11 or more claims each, at $1,311,481 in total drug cost. In 2023, CMS named 1,220 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Shah for performance year 2024, reported as part of a group. Dr. Shah accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shah as offering telehealth.

Dmand AI links 55 papers to Dr. Shah, published from 2012 to 2023. 2020 was the busiest year, with 7. The most frequent topics are Lung Transplantation, Primary Graft Dysfunction and Lung. Dr. Shah has published most often in Am J Transplant. Dr. Shah's most frequent co-authors are Jason Douglas Christie, MD, Steven R. Hays, MD and Jonathan Paul Singer, MD.

CMS Open Payments shows 6 general payments to Dr. Shah from 3 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 84% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $5,219.

Dmand AI lists 1 award for Dr. Shah, most recently CMS Stage 1 EHR in 2013.

Dr. Shah graduated from Wayne State University School Of Medicine in 2005.

Dr. Shah is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.